scholarly journals Prediction and Modeling of Neuropsychological Scores in Alzheimer’s Disease Using Multimodal Neuroimaging Data and Artificial Neural Networks

2022 ◽  
Vol 15 ◽  
Author(s):  
Seyed Hani Hojjati ◽  
Abbas Babajani-Feremi ◽  

Background: In recent years, predicting and modeling the progression of Alzheimer’s disease (AD) based on neuropsychological tests has become increasingly appealing in AD research.Objective: In this study, we aimed to predict the neuropsychological scores and investigate the non-linear progression trend of the cognitive declines based on multimodal neuroimaging data.Methods: We utilized unimodal/bimodal neuroimaging measures and a non-linear regression method (based on artificial neural networks) to predict the neuropsychological scores in a large number of subjects (n = 1143), including healthy controls (HC) and patients with mild cognitive impairment non-converter (MCI-NC), mild cognitive impairment converter (MCI-C), and AD. We predicted two neuropsychological scores, i.e., the clinical dementia rating sum of boxes (CDRSB) and Alzheimer’s disease assessment scale cognitive 13 (ADAS13), based on structural magnetic resonance imaging (sMRI) and positron emission tomography (PET) biomarkers.Results: Our results revealed that volumes of the entorhinal cortex and hippocampus and the average fluorodeoxyglucose (FDG)-PET of the angular gyrus, temporal gyrus, and posterior cingulate outperform other neuroimaging features in predicting ADAS13 and CDRSB scores. Compared to a unimodal approach, our results showed that a bimodal approach of integrating the top two neuroimaging features (i.e., the entorhinal volume and the average FDG of the angular gyrus, temporal gyrus, and posterior cingulate) increased the prediction performance of ADAS13 and CDRSB scores in the converting and stable stages of MCI and AD. Finally, a non-linear AD progression trend was modeled to describe the cognitive decline based on neuroimaging biomarkers in different stages of AD.Conclusion: Findings in this study show an association between neuropsychological scores and sMRI and FDG-PET biomarkers from normal aging to severe AD.

Author(s):  
Pedro Miguel Rodrigues ◽  
Diamantino Rui Freitas ◽  
João Paulo Teixeira ◽  
Dílio Alves ◽  
Carolina Garrett

The World's health systems are now facing a global problem known as Alzheimer's disease (AD) that mainly affects the elderly. The goal of this work is to perform a classification methodology skilled with Artificial Neural Networks (ANN) to improve the discrimination accuracy amongst patients at AD different stages comparatively to the state-of-art. For that, several study features that characterized the Electroencephalogram (EEG) signals “slow-down” were extracted and presented to the ANN entries in order to classify the dataset. The classification results achieved in the present work are promising concerning AD early diagnosis and they show that EEG can be a good tool for AD detection (Controls (C) vs AD: accuracy 95%; C vs Mild-cognitive Impairment (MCI): accuracy 77%; MCI vs AD: accuracy 83%; All vs All: accuracy 90%).


2019 ◽  
Vol 64 ◽  
pp. 190-199 ◽  
Author(s):  
Chin-Fu Liu ◽  
Shreyas Padhy ◽  
Sandhya Ramachandran ◽  
Victor X. Wang ◽  
Andrew Efimov ◽  
...  

2021 ◽  
Author(s):  
Sheng Liu ◽  
Arjun Masurkar ◽  
Henry Rusinek ◽  
Jingyun Chen ◽  
Ben Zhang ◽  
...  

Early diagnosis of Alzheimer's disease plays a pivotal role in patient care and clinical trials. In this study, we have developed a new approach based on 3D deep convolutional neural networks to accurately differentiate mild Alzheimer's disease dementia from mild cognitive impairment and cognitively normal individuals using structural MRIs. For comparison, we have built a reference model based on the volumes and thickness of previously reported brain regions that are known to be implicated in disease progression. We validate both models on an internal held-out cohort from The Alzheimer's Disease Neuroimaging Initiative (ADNI) and on an external independent cohort from The National Alzheimer's Coordinating Center (NACC). The deep-learning model is more accurate and significantly faster than the volume/thickness model. The model can also be used to forecast progression: subjects with mild cognitive impairment misclassified as having mild Alzheimer's disease dementia by the model were faster to progress to dementia over time. An analysis of the features learned by the proposed model shows that it relies on a wide range of regions associated with Alzheimer's disease. These findings suggest that deep neural networks can automatically learn to identify imaging biomarkers that are predictive of Alzheimer's disease, and leverage them to achieve accurate early detection of the disease.


Sign in / Sign up

Export Citation Format

Share Document